Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. - Hollander,E.; Baldini-Rossi,N.; Sood,E.; Pallanti,S. (Int J Neuropsychopharmacol, 2003)